ACAD:NASDAQ
ACADIA Pharmaceuticals Inc
$27.88
arrow_upward
+0.50%(+0.14) 1D
Sep 11, 12:30:08 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACAD...
Open
$27.98
High
$28.24
Low
$27.74
Mkt. cap
4.80B
Avg. vol.
1.65M
Volume
253.74K
P/E ratio
12.60
52-wk high
$30.96
52-wk low
$19.69
EPS
$2.21
Beta
0.86
Shares outstanding
172.31M
No. of employees
797
Open
$27.98
High
$28.24
Low
$27.74
Mkt. cap
4.80B
Avg. vol.
1.65M
Volume
253.74K
P/E ratio
12.60
52-wk high
$30.96
52-wk low
$19.69
EPS
$2.21
Beta
0.86
Shares outstanding
172.31M
No. of employees
797
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 month ago
ACAD Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock Declines - Estimate Dispersion
Profile
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California. Wikipedia
About ACADIA Pharmaceuticals Inc
CEOCatherine Owen Adams
Employees797
Founded1993
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websiteacadia.com